Choon S.E.a· Lebwohl M.G.b· Turki H.c· Zheng M.d· Burden A.D.e· Li L.f· Quaresma M.g· Thoma C.h· Bachelez H.i

Author affiliations

aDepartment of Dermatology, Hospital Sultanah Aminah, Clinical School Johor Bahru, Monash University Malaysia, Johor Bahru, Malaysia
bIcahn School of Medicine at Mount Sinai, New York, NY, USA
cDepartment of Dermatology, Hedi Chaker Hospital, University of Sfax, Sfax, Tunisia
dDepartment of Dermatology, Second Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China
eInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK
fBoehringer Ingelheim (China), Investment Co., Ltd., Shanghai, China
gBoehringer Ingelheim International GmbH, Ingelheim, Germany
hBoehringer Ingelheim International GmbH, Biberach, Germany
iService de Dermatologie, Assistance Publique – Hôpitaux de Paris Hôpital Saint-Louis, and INSERM Unité 1163, Imagine Institute of Genetic Diseases, Université Paris Cité, Paris, France